Skip to main content
. Author manuscript; available in PMC: 2013 May 1.
Published in final edited form as: J Neurochem. 2012 Mar 14;121(3):486–494. doi: 10.1111/j.1471-4159.2012.07699.x

Figure 5.

Figure 5

Levels of the proteasomal activator 19S are slighlty increased in chronic EAE. Left two panels show representative immunoblots of cerebellum homogenates from control and EAE mice developed with antibodies against the Rpt4 subunit of the 19S particle (a) and Lys-48 poly-ubiquitin (b). Right panels depict the corresponding levels of each of these proteins, which were calculated by dividing the band intensity (in the case of the Rpt4 subunit) or lane intensity (in the case of Lys-48 poly-ubiquitin) on the western blot by that of the corresponding coomassie blue stained lane. Values represent the mean ± SEM of 3 animals per experimental group. *p<0.05. NS, not significant.